HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
Nuhad Ibrahim Selected Research
Nuhad Ibrahim Research Topics
Disease
22
Breast Neoplasms (Breast Cancer)
01/2022 - 07/2003
14
Neoplasms (Cancer)
11/2021 - 03/2003
7
Brain Neoplasms (Brain Tumor)
01/2022 - 03/2016
4
Disease Progression
01/2022 - 01/2009
3
Neoplasm Metastasis (Metastasis)
01/2022 - 01/2013
3
Triple Negative Breast Neoplasms
10/2020 - 11/2011
3
Pathologic Complete Response
01/2011 - 08/2005
2
Diarrhea
01/2020 - 03/2016
2
Neurologic Manifestations (Neurological Manifestations)
01/2019 - 03/2016
1
Meningeal Carcinomatosis
01/2020
1
Central Nervous System Diseases (CNS Diseases)
03/2016
1
Carcinogenesis
08/2015
1
Febrile Neutropenia
01/2011
1
Thrombocytopenia (Thrombopenia)
01/2011
1
Infections
01/2011
1
Fatigue
02/2004
1
Arthralgia (Joint Pain)
02/2004
1
Cardiotoxicity
07/2003
1
Fever (Fevers)
07/2003
1
Leukemia
03/2003
Drug/Important Bio-Agent (IBA)
5
taxane
IBA
07/2019 - 08/2005
5
Doxorubicin (Adriamycin)
FDA Link
Generic
01/2011 - 02/2004
5
Cyclophosphamide (Cytoxan)
FDA Link
Generic
01/2011 - 07/2003
4
Anthracyclines
IBA
07/2019 - 04/2006
3
Trastuzumab (Herceptin)
FDA Link
01/2021 - 07/2003
3
ErbB Receptors (EGF Receptor)
IBA
10/2020 - 03/2016
3
Peptides (Polypeptides)
IBA
01/2020 - 01/2009
3
neratinib
IBA
01/2020 - 03/2016
3
Proteins (Proteins, Gene)
FDA Link
01/2013 - 01/2009
3
Fluorouracil (Carac)
FDA Link
Generic
01/2011 - 08/2005
3
Paclitaxel (Taxol)
FDA Link
Generic
09/2006 - 02/2004
2
etirinotecan pegol
IBA
01/2022 - 07/2019
2
Hormones (Hormone)
IBA
10/2020 - 01/2009
2
Estrogen Receptors
IBA
10/2020 - 05/2011
2
Pharmaceutical Preparations
IBA
01/2020 - 01/2020
2
Capecitabine (Xeloda)
FDA Link
07/2019 - 01/2019
2
human ERBB2 protein
IBA
01/2019 - 03/2016
2
Granulocyte Colony-Stimulating Factor (G-CSF)
IBA
01/2011 - 07/2003
1
talimogene laherparepvec
IBA
11/2021
1
Radioisotopes (Radionuclides)
IBA
01/2021
1
Epidermal Growth Factor (EGF)
IBA
01/2021
1
pertuzumab
IBA
01/2021
1
talazoparib
IBA
10/2020
1
Progesterone Receptors (Progesterone Receptor)
IBA
10/2020
1
paclitaxel-Angiopep-2 conjugate
IBA
01/2020
1
Steroids
IBA
01/2019
1
Loperamide (Imodium)
FDA Link
Generic
03/2016
1
Adrenal Cortex Hormones (Corticosteroids)
IBA
03/2016
1
Epirubicin (Ellence)
FDA Link
Generic
08/2015
1
Protein Isoforms (Isoforms)
IBA
08/2015
1
Cyclin E
IBA
08/2015
1
dinaciclib
IBA
08/2015
1
Glycopeptides
IBA
12/2012
1
Antigens
IBA
12/2012
1
Indicators and Reagents (Reagents)
IBA
12/2012
1
Polysaccharides (Glycans)
IBA
12/2012
1
Mucin-1 (CA 15-3 Antigen)
IBA
12/2012
1
Galactosyltransferases
IBA
12/2012
1
Mucins
IBA
12/2012
1
Epitopes
IBA
12/2012
1
Monoclonal Antibodies
IBA
12/2012
1
Dasatinib (BMS 354825)
FDA Link
11/2011
1
src-Family Kinases
IBA
11/2011
1
Heat-Shock Proteins (Heat-Shock Protein)
IBA
01/2009
1
Vaccines
IBA
01/2009
1
epitumomab
IBA
01/2009
1
DNA Vaccines
IBA
01/2009
1
Camptothecin
IBA
04/2006
1
rubitecan
IBA
04/2006
1
Albumin-Bound Paclitaxel
FDA Link
01/2006
1
Phenobarbital (Luminal)
FDA Link
08/2005
1
tariquidar (XR9576)
IBA
08/2005
1
Member 1 Subfamily B ATP Binding Cassette Transporter
IBA
08/2005
1
Cytokines
IBA
02/2004
1
Interleukin-10 (Interleukin 10)
IBA
02/2004
1
Docetaxel (Taxotere)
FDA Link
07/2003
1
Anti-Bacterial Agents (Antibiotics)
IBA
07/2003
1
Clofarabine (Clolar)
FDA Link
03/2003
Therapy/Procedure
10
Drug Therapy (Chemotherapy)
01/2022 - 02/2004
8
Therapeutics
01/2021 - 07/2003
3
Radiotherapy
01/2021 - 03/2016
2
Immunotherapy
11/2021 - 01/2009
2
Neoadjuvant Therapy
05/2011 - 01/2011
1
Craniotomy
01/2020